A Dose of Prevention is Worth a Pound of Cure: Respiratory Syncytial Virus Immunity for a Safer Community

Document Type

Article

Publication Date

5-2025

Identifier

DOI: 10.1016/j.yfpn.2025.01.009

Abstract

Respiratory syncytial virus (RSV) is the leading cause of hospitalization of infants in the United States. Symptoms range from cold-like illness to lower respiratory tract disease such as pneumonia and bronchiolitis.

Journal Title

Advances in Family Practice Nursing

Volume

7

Issue

1

First Page

227

Last Page

238

Keywords

Respiratory syncytial virus (RSV); Bronchiolitis; Beyfortus (Nirsevimab); Abrysvo (RSV preF); Synagis (Palivizumab)

Library Record

Share

COinS